U.S. markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
140.49-10.29 (-6.82%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/29/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.76B1.63B736.31M1.29B1.20B
Enterprise Value 3
1.63B1.54B657.24M1.20B1.10B
Trailing P/E
23.4122.069.7218.0217.56
Forward P/E 1
N/AN/AN/AN/A12.00
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.352.301.061.931.97
Price/Book (mrq)
15.1014.737.0211.599.55
Enterprise Value/Revenue 3
2.157.003.687.065.80
Enterprise Value/EBITDA 6
17.0851.4326.0960.3251.37

Trading Information

Stock Price History

Beta (5Y Monthly) 1.20
52-Week Change 326.22%
S&P500 52-Week Change 36.23%
52 Week High 3184.29
52 Week Low 349.03
50-Day Moving Average 3162.01
200-Day Moving Average 3136.61

Share Statistics

Avg Vol (3 month) 3206.56k
Avg Vol (10 day) 3154.38k
Shares Outstanding 511.77M
Float 10.28M
% Held by Insiders 14.65%
% Held by Institutions 1115.36%
Shares Short (Oct 14, 2020) 4918.53k
Short Ratio (Oct 14, 2020) 45.94
Short % of Float (Oct 14, 2020) 411.29%
Short % of Shares Outstanding (Oct 14, 2020) 47.81%
Shares Short (prior month Sep 14, 2020) 41.01M

Dividends & Splits

Forward Annual Dividend Rate 44.52
Forward Annual Dividend Yield 43.00%
Trailing Annual Dividend Rate 34.14
Trailing Annual Dividend Yield 32.75%
5 Year Average Dividend Yield 4N/A
Payout Ratio 464.69%
Dividend Date 3Nov 05, 2020
Ex-Dividend Date 4Sep 20, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 10.04%
Operating Margin (ttm)12.10%

Management Effectiveness

Return on Assets (ttm)25.82%
Return on Equity (ttm)62.77%

Income Statement

Revenue (ttm)759.15M
Revenue Per Share (ttm)64.76
Quarterly Revenue Growth (yoy)17.60%
Gross Profit (ttm)536.86M
EBITDA 96.66M
Net Income Avi to Common (ttm)76.19M
Diluted EPS (ttm)6.39
Quarterly Earnings Growth (yoy)2.60%

Balance Sheet

Total Cash (mrq)145.39M
Total Cash Per Share (mrq)12.41
Total Debt (mrq)12.01M
Total Debt/Equity (mrq)10.29
Current Ratio (mrq)1.79
Book Value Per Share (mrq)9.97

Cash Flow Statement

Operating Cash Flow (ttm)121.3M
Levered Free Cash Flow (ttm)105.25M